MIDES: A Study to Investigate the Possible Causes of Secondary Effects During Use of Peripheral Midline Type Catheter in Patients Hospitalized in Different Care Settings

Sponsor
Azienda Ospedaliera Città della Salute e della Scienza di Torino (Other)
Overall Status
Completed
CT.gov ID
NCT04391205
Collaborator
(none)
211
1
22.1
9.5

Study Details

Study Description

Brief Summary

Although the use of peripheral venous catheters (CVP) with brachial insertion with echo-guide (Midline) has increased significantly over the last 5-10 years, there are no sensitive data concerning complications in the literature during their use, particularly as regards incidence of thrombotic complication.The prospective observational study will enroll all the patients admitted to Home Health Hospitalization service, Geriatric Department and Intermediate Care service, to whom a Midline-type CVP will be placed for infusional therapy and who will give their consent to participate.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    211 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Safety and Efficiency oh the Use of Midline Peripheral Venous Catheter (MIDES)
    Actual Study Start Date :
    Apr 26, 2017
    Actual Primary Completion Date :
    Feb 28, 2019
    Actual Study Completion Date :
    Feb 28, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants with Peripheral deep venous thrombosis (DVP) suspected with Compression ultrasound (CUS) and confirmed by echodoppler [Once a week from the implant day until CVP removal or patient discharge, whichever came first, assessed up to 40 days]

      Deep vein thrombosis is investigated with Compression ultrasound (CUS) technique, scheduled once a week from the implant day or performed at the time of occurrence of device malfunctions or at the onset of symptoms resulting from thrombotic complications; echodoppler tecnique is used to confirm diagnosis of thrombosis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    45 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects admitted to wards adhering to the study (Home Health Hospitalization service, Geriatric Department and Intermediate Care service)

    • Subjects submitted to Midline type venous catheter insertion

    Exclusion Criteria:
    • History of deep venous thrombosis or pulmonary embolism

    • Be hospitalized for less than a week

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Marinello Renata Turin Italy 10126

    Sponsors and Collaborators

    • Azienda Ospedaliera Città della Salute e della Scienza di Torino

    Investigators

    • Principal Investigator: Renata Marinello, MD, PhD, OAU Città della Salute e della Scienza di Torino, Turin, Italy

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dott.ssa RENATA MARINELLO, Principal Investigator, Azienda Ospedaliera Città della Salute e della Scienza di Torino
    ClinicalTrials.gov Identifier:
    NCT04391205
    Other Study ID Numbers:
    • 0041902
    First Posted:
    May 18, 2020
    Last Update Posted:
    May 19, 2020
    Last Verified:
    May 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dott.ssa RENATA MARINELLO, Principal Investigator, Azienda Ospedaliera Città della Salute e della Scienza di Torino
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 19, 2020